Moderna (MRNA)
Moderna on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances).
32.6M
Short interest
settlement 2026-10-15
1.8
Days to cover
-0.1 days vs prior
56.4%
Short share of volume
2026-11-02
453
Fails to deliver
settlement 2026-10-13
Thu 5 Nov
Next earnings
estimated date
-$62.6M
Insider flow, 90 days
0 buys, 12 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in MRNA is 32,603,398 shares, down 269,389 shares over the last month. Over the last 48 readings it ranged from 30,863,202 shares (30 September 2026) to 71,505,698 shares (30 January 2026). The latest reading sits at the bottom of that range. At the reported average volume of 18.3M shares a day that is 1.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/mrna" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 32,603,398 | +5.6% | 18,289,385 | 1.78 |
| 2026-09-30 | 30,863,202 | -6.1% | 16,889,344 | 1.83 |
| 2026-09-15 | 32,872,787 | -16.0% | 13,012,461 | 2.53 |
| 2026-08-31 | 39,151,532 | -25.9% | 50,157,233 | 1.00 |
| 2026-08-14 | 52,809,184 | +6.1% | 5,773,145 | 9.15 |
| 2026-07-31 | 49,768,882 | -5.0% | 4,868,200 | 10.22 |
| 2026-07-15 | 52,401,842 | -1.5% | 8,626,893 | 6.07 |
| 2026-06-30 | 53,185,640 | -9.3% | 11,529,682 | 4.61 |
| 2026-06-15 | 58,664,960 | +1.5% | 5,598,691 | 10.48 |
| 2026-05-29 | 57,806,124 | -0.5% | 4,710,739 | 12.27 |
| 2026-05-15 | 58,071,415 | -0.4% | 10,322,790 | 5.63 |
| 2026-04-30 | 58,309,643 | -1.9% | 5,747,583 | 10.15 |
| 2026-04-15 | 59,437,562 | -2.0% | 5,192,193 | 11.45 |
| 2026-03-31 | 60,649,602 | -8.4% | 6,704,912 | 9.05 |
| 2026-03-13 | 66,188,177 | -5.8% | 10,748,221 | 6.16 |
| 2026-02-27 | 70,233,907 | -1.6% | 8,688,614 | 8.08 |
| 2026-02-13 | 71,341,687 | -0.2% | 10,886,356 | 6.55 |
| 2026-01-30 | 71,505,698 | +1.8% | 15,740,115 | 4.54 |
| 2026-01-15 | 70,268,867 | +2.9% | 13,291,708 | 5.29 |
| 2025-12-31 | 68,321,865 | -1.9% | 9,920,925 | 6.89 |
| 2025-12-15 | 69,679,477 | +2.4% | 10,101,670 | 6.90 |
| 2025-11-28 | 68,075,313 | +5.8% | 9,366,839 | 7.27 |
| 2025-11-14 | 64,356,094 | +1.1% | 11,379,459 | 5.66 |
| 2025-10-31 | 63,656,197 | -2.1% | 12,160,619 | 5.23 |
| 2025-10-15 | 65,036,951 | +1.1% | 9,397,529 | 6.92 |
| 2025-09-30 | 64,337,988 | +1.6% | 11,546,655 | 5.57 |
| 2025-09-15 | 63,310,000 | +5.8% | 13,053,475 | 4.85 |
| 2025-08-29 | 59,842,399 | -4.8% | 9,612,400 | 6.23 |
| 2025-08-15 | 62,826,303 | -0.3% | 9,004,764 | 6.98 |
| 2025-07-31 | 63,015,386 | -4.9% | 7,648,881 | 8.24 |
| 2025-07-15 | 66,236,681 | +1.0% | 10,714,408 | 6.18 |
| 2025-06-30 | 65,594,054 | +3.2% | 9,119,935 | 7.19 |
| 2025-06-13 | 63,564,116 | -3.5% | 9,349,096 | 6.80 |
| 2025-05-30 | 65,855,374 | -2.1% | 16,710,119 | 3.94 |
| 2025-05-15 | 67,270,523 | +11.7% | 11,666,078 | 5.77 |
| 2025-04-30 | 60,217,408 | +7.0% | 6,306,485 | 9.55 |
| 2025-04-15 | 56,305,788 | +13.1% | 11,201,592 | 5.03 |
| 2025-03-31 | 49,799,445 | +6.2% | 8,255,143 | 6.03 |
| 2025-03-14 | 46,881,859 | +4.0% | 11,271,564 | 4.16 |
| 2025-02-28 | 45,063,081 | +6.5% | 11,837,325 | 3.81 |
| 2025-02-14 | 42,296,108 | +4.2% | 13,226,877 | 3.20 |
| 2025-01-31 | 40,600,489 | -5.6% | 12,117,430 | 3.35 |
| 2025-01-15 | 43,006,951 | +13.6% | 12,865,489 | 3.34 |
| 2024-12-31 | 37,847,737 | -4.2% | 8,631,499 | 4.38 |
| 2024-12-13 | 39,488,336 | -3.3% | 6,869,131 | 5.75 |
| 2024-11-29 | 40,837,234 | +2.4% | 9,292,568 | 4.39 |
| 2024-11-15 | 39,863,421 | +15.9% | 11,579,058 | 3.44 |
| 2024-10-31 | 34,383,773 | +3.4% | 4,475,946 | 7.68 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of MRNA volume is 56.4%, down 8.2 points over the last five sessions. Over the last 30 readings it ranged from 52.5% (29 October 2026) to 71.1% (19 October 2026). The latest reading is 6.1 points below the 30-session average of 62.5%, on 4.1M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 2.3M | 4.1M | 56.4% | 26,395 |
| 2026-10-30 | 2.2M | 4.0M | 55.8% | 9,414 |
| 2026-10-29 | 2.8M | 5.4M | 52.5% | 6,130 |
| 2026-10-28 | 3.5M | 6.3M | 54.7% | 5,295 |
| 2026-10-27 | 5.5M | 9.6M | 57.1% | 22,558 |
| 2026-10-26 | 5.2M | 8.1M | 64.6% | 20,081 |
| 2026-10-23 | 6.8M | 11.3M | 60.1% | 893,136 |
| 2026-10-22 | 16.9M | 26.3M | 64.5% | 1,332,361 |
| 2026-10-21 | 5.5M | 7.9M | 70.2% | 46,285 |
| 2026-10-20 | 6.2M | 9.0M | 68.4% | 43,392 |
| 2026-10-19 | 6.7M | 9.4M | 71.1% | 635,192 |
| 2026-10-16 | 7.5M | 11.4M | 66.2% | 547,452 |
| 2026-10-15 | 6.2M | 9.1M | 67.3% | 69,512 |
| 2026-10-14 | 5.5M | 8.4M | 64.8% | 25,273 |
| 2026-10-13 | 4.4M | 6.8M | 64.8% | 10,529 |
| 2026-10-12 | 4.3M | 7.1M | 61.1% | 19,419 |
| 2026-10-09 | 10.0M | 16.1M | 62.0% | 11,304 |
| 2026-10-08 | 4.6M | 6.8M | 68.7% | 928 |
| 2026-10-07 | 4.8M | 7.4M | 64.3% | 15,369 |
| 2026-10-06 | 6.5M | 9.9M | 65.7% | 34,416 |
| 2026-10-05 | 5.4M | 9.3M | 57.7% | 31,228 |
| 2026-10-02 | 3.1M | 4.8M | 63.8% | 4,502 |
| 2026-10-01 | 4.6M | 7.5M | 61.4% | 4,864 |
| 2026-09-30 | 5.2M | 9.0M | 57.7% | 29,139 |
| 2026-09-29 | 4.4M | 6.9M | 62.8% | 4,642 |
| 2026-09-28 | 3.6M | 5.9M | 61.8% | 14,792 |
| 2026-09-25 | 4.4M | 7.2M | 60.8% | 8,087 |
| 2026-09-24 | 5.8M | 8.9M | 64.8% | 19,338 |
| 2026-09-23 | 5.6M | 9.1M | 61.3% | 57,993 |
| 2026-09-22 | 8.0M | 12.7M | 62.6% | 32,605 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in MRNA is 453 shares, down 447 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (1 September 2026) to 190,955 shares (21 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 453 | $213.74 | $97K |
| 2026-10-09 | 900 | $197.00 | $177K |
| 2026-10-08 | 3,922 | $196.48 | $771K |
| 2026-10-06 | 1,168 | $203.21 | $237K |
| 2026-10-05 | 5,344 | $190.01 | $1.0M |
| 2026-10-02 | 3,798 | $188.94 | $718K |
| 2026-09-29 | 3,673 | $197.28 | $725K |
| 2026-09-28 | 3,987 | $198.88 | $793K |
| 2026-09-25 | 31,991 | $194.82 | $6.2M |
| 2026-09-23 | 55 | $182.56 | $10K |
| 2026-09-22 | 4,581 | $172.94 | $792K |
| 2026-09-15 | 837 | $146.69 | $123K |
| 2026-09-14 | 37,517 | $143.97 | $5.4M |
| 2026-09-11 | 6,064 | $136.62 | $828K |
| 2026-09-08 | 4,944 | $145.55 | $720K |
| 2026-09-04 | 48,318 | $148.87 | $7.2M |
| 2026-09-03 | 38,284 | $150.81 | $5.8M |
| 2026-09-02 | 55,645 | $154.27 | $8.6M |
| 2026-09-01 | 1 | $140.34 | $140 |
| 2026-08-31 | 31,800 | $137.99 | $4.4M |
| 2026-08-28 | 424 | $142.77 | $61K |
| 2026-08-27 | 1,346 | $149.66 | $201K |
| 2026-08-26 | 47,022 | $158.83 | $7.5M |
| 2026-08-24 | 71,375 | $145.13 | $10.4M |
| 2026-08-21 | 190,955 | $133.32 | $25.5M |
| 2026-08-20 | 190 | $174.38 | $33K |
| 2026-08-18 | 7,105 | $64.46 | $458K |
| 2026-08-17 | 3,705 | $63.32 | $235K |
| 2026-08-14 | 1,866 | $63.65 | $119K |
| 2026-08-13 | 2,694 | $63.67 | $172K |
Insider trades
SEC Form 4, newest first. JSONInsiders at MRNA reported 12 open-market sells worth $62.6M in the last 90 days and no open-market buys. Latest filing: Hoge Stephen (President) on 2026-10-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Hoge Stephen | President | Sell | 39K | $220.72 | $8.6M | 1.6M |
| 2026-10-15 | Hoge Stephen | President | Exercise or conversion | 76K | $12.21 | $933K | 1.7M |
| 2026-10-14 | Hoge Stephen | President | Sell | 450 | $214.15 | $96K | 1.6M |
| 2026-10-14 | Hoge Stephen | President | Sell | 39K | $213.47 | $8.3M | 1.6M |
| 2026-10-14 | Hoge Stephen | President | Exercise or conversion | 76K | $12.21 | $933K | 1.6M |
| 2026-10-05 | Mock James M | Chief Financial Officer | Tax withholding | 704 | $190.01 | $134K | 60K |
| 2026-10-05 | Mock James M | Chief Financial Officer | Exercise or conversion | 1K | price not stated in the filing | not stated | 61K |
| 2026-09-15 | Hoge Stephen | President | Sell | 40K | $146.07 | $5.9M | 1.6M |
| 2026-09-15 | Hoge Stephen | President | Exercise or conversion | 76K | $12.21 | $933K | 1.6M |
| 2026-09-14 | Hoge Stephen | President | Sell | 40K | $144.13 | $5.8M | 1.5M |
| 2026-09-14 | Hoge Stephen | President | Exercise or conversion | 76K | $12.21 | $933K | 1.6M |
| 2026-09-10 | Mock James M | Chief Financial Officer | Sell | 15K | $134.49 | $2.0M | 59K |
| 2026-09-10 | Mock James M | Chief Financial Officer | Sell | 20K | $134.49 | $2.7M | 74K |
| 2026-09-10 | Mock James M | Chief Financial Officer | Exercise or conversion | 20K | $30.96 | $614K | 94K |
| 2026-09-04 | Mock James M | Chief Financial Officer | Tax withholding | 6K | $148.87 | $849K | 74K |
| 2026-09-04 | Mock James M | Chief Financial Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 80K |
| 2026-09-04 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 6K | $148.87 | $849K | 81K |
| 2026-09-04 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 87K |
| 2026-09-01 | Hoge Stephen | President | Tax withholding | 4K | $140.34 | $630K | 1.5M |
| 2026-09-01 | Hoge Stephen | President | Exercise or conversion | 9K | price not stated in the filing | not stated | 1.5M |
| 2026-09-01 | Mock James M | Chief Financial Officer | Tax withholding | 1K | $140.34 | $168K | 68K |
| 2026-09-01 | Mock James M | Chief Financial Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 69K |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 1K | $140.34 | $147K | 75K |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 76K |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Sell | 3K | $139.95 | $486K | 74K |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 3K | $30.96 | $107K | 78K |
| 2026-08-28 | Mock James M | Chief Financial Officer | Tax withholding | 160 | $142.77 | $23K | 67K |
| 2026-08-28 | Mock James M | Chief Financial Officer | Exercise or conversion | 329 | price not stated in the filing | not stated | 67K |
| 2026-08-28 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 160 | $142.77 | $23K | 74K |
| 2026-08-28 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 329 | price not stated in the filing | not stated | 74K |
| 2026-08-28 | Hoge Stephen | President | Tax withholding | 296 | $142.77 | $42K | 1.5M |
| 2026-08-28 | Hoge Stephen | President | Exercise or conversion | 611 | price not stated in the filing | not stated | 1.5M |
| 2026-08-27 | Mock James M | Chief Financial Officer | Tax withholding | 375 | $149.66 | $56K | 67K |
| 2026-08-27 | Mock James M | Chief Financial Officer | Exercise or conversion | 774 | price not stated in the filing | not stated | 67K |
| 2026-08-27 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 375 | $149.66 | $56K | 74K |
| 2026-08-27 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 774 | price not stated in the filing | not stated | 74K |
| 2026-08-27 | Hoge Stephen | President | Tax withholding | 695 | $149.66 | $104K | 1.5M |
| 2026-08-27 | Hoge Stephen | President | Exercise or conversion | 1K | price not stated in the filing | not stated | 1.5M |
| 2026-08-06 | Bancel Stephane | Chief Executive Officer | Exercise or conversion | 252K | $19.15 | $4.8M | 6.4M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 187K | $58.79 | $11.0M | 6.2M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 40K | $58.12 | $2.3M | 6.4M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 125K | $56.96 | $7.1M | 6.4M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Sell | 147K | $56.21 | $8.3M | 6.5M |
| 2026-08-05 | Bancel Stephane | Chief Executive Officer | Exercise or conversion | 499K | $19.15 | $9.6M | 6.7M |
| 2026-07-15 | Hoge Stephen | President | Sell | 53K | $67.60 | $3.6M | 1.5M |
| 2026-07-15 | Hoge Stephen | President | Exercise or conversion | 16K | $19.15 | $309K | 1.5M |
| 2026-07-15 | Hoge Stephen | President | Exercise or conversion | 37K | $19.15 | $713K | 1.5M |
| 2026-07-02 | Mock James M | Chief Financial Officer | Tax withholding | 703 | $72.50 | $51K | 66K |
| 2026-07-02 | Mock James M | Chief Financial Officer | Exercise or conversion | 1K | price not stated in the filing | not stated | 67K |
| 2026-06-15 | Hoge Stephen | President | Sell | 53K | $51.37 | $2.7M | 1.5M |
| 2026-06-15 | Hoge Stephen | President | Exercise or conversion | 37K | $19.15 | $713K | 1.5M |
| 2026-06-15 | Hoge Stephen | President | Exercise or conversion | 16K | $19.15 | $309K | 1.5M |
| 2026-06-05 | Mock James M | Chief Financial Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 71K |
| 2026-06-05 | Mock James M | Chief Financial Officer | Tax withholding | 6K | $51.59 | $294K | 66K |
| 2026-06-05 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 79K |
| 2026-06-05 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 6K | $51.59 | $294K | 74K |
| 2026-06-04 | Klinger Shannon Thyme | Chief Legal Officer | Sell | 3K | $50.00 | $174K | 67K |
| 2026-06-04 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 3K | $30.96 | $107K | 71K |
| 2026-06-01 | Hoge Stephen | President | Exercise or conversion | 9K | price not stated in the filing | not stated | 1.5M |
| 2026-06-01 | Hoge Stephen | President | Tax withholding | 4K | $47.19 | $212K | 1.5M |
| 2026-06-01 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 1K | $47.19 | $49K | 67K |
| 2026-06-01 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 69K |
| 2026-06-01 | Mock James M | Chief Financial Officer | Tax withholding | 1K | $47.19 | $56K | 60K |
| 2026-06-01 | Mock James M | Chief Financial Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 61K |
| 2026-05-28 | Hoge Stephen | President | Exercise or conversion | 610 | price not stated in the filing | not stated | 1.5M |
| 2026-05-28 | Hoge Stephen | President | Tax withholding | 295 | $47.61 | $14K | 1.5M |
| 2026-05-28 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 328 | price not stated in the filing | not stated | 67K |
| 2026-05-28 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 159 | $47.61 | $8K | 66K |
| 2026-05-28 | Mock James M | Chief Financial Officer | Exercise or conversion | 328 | price not stated in the filing | not stated | 58K |
| 2026-05-28 | Mock James M | Chief Financial Officer | Tax withholding | 159 | $47.61 | $8K | 58K |
| 2026-05-27 | Hoge Stephen | President | Tax withholding | 695 | $47.03 | $33K | 1.5M |
| 2026-05-27 | Hoge Stephen | President | Exercise or conversion | 1K | price not stated in the filing | not stated | 1.5M |
| 2026-05-27 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 773 | price not stated in the filing | not stated | 67K |
| 2026-05-27 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 374 | $47.03 | $18K | 66K |
| 2026-05-27 | Mock James M | Chief Financial Officer | Exercise or conversion | 773 | price not stated in the filing | not stated | 59K |
| 2026-05-27 | Mock James M | Chief Financial Officer | Tax withholding | 374 | $47.03 | $18K | 58K |
| 2026-05-21 | AFEYAN NOUBAR | Director | Sell | 9K | $46.84 | $434K | 4K |
| 2026-05-21 | AFEYAN NOUBAR | Director | Exercise or conversion | 9K | $19.15 | $177K | 13K |
| 2026-05-15 | Hoge Stephen | President | Sell | 53K | $48.40 | $2.6M | 1.5M |
| 2026-05-15 | Hoge Stephen | President | Exercise or conversion | 16K | $19.15 | $309K | 1.5M |
| 2026-05-15 | Hoge Stephen | President | Exercise or conversion | 37K | $19.15 | $713K | 1.5M |
| 2026-05-01 | Hussain Abbas | Director | Sell | 6K | $46.63 | $265K | 12K |
| 2026-04-30 | Tallett Elizabeth E | Director | Exercise or conversion | 4K | price not stated in the filing | not stated | 5K |
| 2026-04-30 | Nader Francois | Director | Exercise or conversion | 12K | price not stated in the filing | not stated | 33K |
| 2026-04-30 | NABEL ELIZABETH G | Director | Exercise or conversion | 16K | price not stated in the filing | not stated | 19K |
| 2026-04-30 | Hussain Abbas | Director | Exercise or conversion | 16K | price not stated in the filing | not stated | 18K |
| 2026-04-30 | Rubenstein David M. | Director | Exercise or conversion | 8K | price not stated in the filing | not stated | 10K |
| 2026-04-30 | Horning Sandra | Director | Exercise or conversion | 16K | price not stated in the filing | not stated | 19K |
| 2026-04-02 | Mock James M | Chief Financial Officer | Tax withholding | 703 | $50.03 | $35K | 58K |
| 2026-04-02 | Mock James M | Chief Financial Officer | Exercise or conversion | 1K | price not stated in the filing | not stated | 58K |
| 2026-03-05 | Mock James M | Chief Financial Officer | Tax withholding | 6K | $57.80 | $330K | 57K |
| 2026-03-05 | Mock James M | Chief Financial Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 63K |
| 2026-03-05 | Klinger Shannon Thyme | Chief Legal Officer | Tax withholding | 6K | $57.80 | $330K | 66K |
| 2026-03-05 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 12K | price not stated in the filing | not stated | 71K |
| 2026-03-02 | Klinger Shannon Thyme | Chief Legal Officer | Exercise or conversion | 14K | $30.96 | $430K | 74K |
| 2026-03-02 | Klinger Shannon Thyme | Chief Legal Officer | Sell | 14K | $52.29 | $726K | 60K |
| 2026-02-27 | Mock James M | Chief Financial Officer | Tax withholding | 5K | $51.71 | $248K | 51K |
| 2026-02-27 | Mock James M | Chief Financial Officer | Exercise or conversion | 774 | price not stated in the filing | not stated | 46K |
| 2026-02-27 | Mock James M | Chief Financial Officer | Exercise or conversion | 329 | price not stated in the filing | not stated | 46K |
| 2026-02-27 | Mock James M | Chief Financial Officer | Tax withholding | 160 | $51.71 | $8K | 45K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON19 Form 144 notices on file for MRNA worth $85.6M at the prices reported; 7 in the last 90 days worth $62.8M. Latest: Hoge Stephen filed on 2026-10-15 to sell 39,145 shares ($8.6M) from 2026-10-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-15 | Hoge StephenOfficer | 39K | $8.6M | 0.010% | 2026-10-15 | Fidelity Brokerage Services LLC |
| 2026-10-14 | Hoge StephenOfficer | 39K | $8.4M | 0.010% | 2026-10-14 | Fidelity Brokerage Services LLC |
| 2026-09-15 | Hoge StephenOfficer | 40K | $5.9M | 0.010% | 2026-09-15 | Fidelity Brokerage Services LLC |
| 2026-09-14 | Hoge StephenOfficer | 40K | $5.8M | 0.010% | 2026-09-14 | Fidelity Brokerage Services LLC |
| 2026-09-10 | Mock James MOfficer | 35K | $4.7M | 0.009% | 2026-09-10 | Fidelity Brokerage Services LLC |
| 2026-09-01 | Klinger Shannon ThymeOfficer | 3K | $486K | 0.001% | 2026-09-01 | Fidelity Brokerage Services LLC |
| 2026-08-05 | Bancel StephaneOfficer, Director | 499K | $29.0M | 0.125% | 2026-08-05 | Fidelity Brokerage Services LLC |
| 2026-07-15 | Hoge StephenOfficer | 53K | $3.6M | 0.013% | 2026-07-15 | Fidelity Brokerage Services LLC |
| 2026-06-18 | SAGAN PAULFormer Director | 26K | $1.7M | 0.006% | 2026-06-18 | Fidelity Brokerage Services LLC |
| 2026-06-15 | Hoge StephenOfficer | 53K | $2.7M | 0.013% | 2026-06-15 | Fidelity Brokerage Services LLC |
| 2026-06-04 | Klinger Shannon ThymeOfficer | 3K | $174K | 0.001% | 2026-06-04 | Fidelity Brokerage Services LLC |
| 2026-05-21 | Flagship Pioneering, LLCAffiliate | 9K | $434K | 0.002% | 2026-05-21 | Fidelity Brokerage Services LLC |
| 2026-05-15 | Hoge StephenOfficer | 53K | $2.6M | 0.013% | 2026-05-15 | Fidelity Brokerage Services LLC |
| 2026-05-08 | SAGAN PAULFormer Director | 37K | $2.0M | 0.009% | 2026-05-08 | Fidelity Brokerage Services LLC |
| 2026-05-01 | Hussain AbbasDirector | 6K | $265K | 0.001% | 2026-05-01 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Klinger Shannon ThymeOfficer | 14K | $726K | 0.004% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-02-23 | Hoge StephenOfficer | 160K | $7.8M | 0.041% | 2026-02-23 | Fidelity Brokerage Services LLC |
| 2025-12-11 | Flagship Pioneering Inc.Affiliate | 24K | $703K | 0.006% | 2025-12-11 | Fidelity Brokerage Services LLC |
| 2025-12-09 | Hussain AbbasDirector | 504 | $14K | 0.000% | 2025-12-09 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of MRNA in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 13.1% of the class (51,803,891 shares), filed 2026-08-06 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-12 | 13G | Capital World Investorsinvestment adviser | 22.3M | 5.6% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | FMR LLCparent holding company | 51.8M | 13.1% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 2 | Abigail P. Johnsonindividual | 51.8M | 13.1% | 2026-06-30 |
| 2026-07-24 | 13G/Ano. 7 | BAILLIE GIFFORD & COinvestment adviser | 18.2M | 4.6% | 2026-06-30 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 25.9M | 6.5% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 6 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding MRNA at their latest 13F. JSON7 of the 30 tracked managers held MRNA at their latest 13F, $592.0M in total at quarter-end prices. Two Sigma Investments is the largest at $503.8M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 7.2M | $503.8M | 0.36% | -1.9M |
| AQR Capital Management | 2026-06-30 | 479K | $33.6M | 0.01% | +441K |
| Millennium Management | 2026-06-30 | 439K | $30.7M | 0.01% | -581K |
| Citadel Advisors | 2026-06-30 | 294K | $20.6M | 0.00% | -195K |
| D. E. Shaw & Co. | 2026-06-30 | 25K | $1.7M | 0.00% | -642K |
| Bridgewater Associates | 2026-06-30 | 12K | $807K | 0.00% | -63K |
| Fisher Asset Management | 2026-06-30 | 11K | $760K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Moderna reported revenue of $145.0M, up 2.1% from the same quarter a year earlier, and net loss of $782.0M (-1.97 diluted EPS). In FY 2025 it generated -$1.87B of operating cash flow and spent $2.0M on buybacks. As of 2026-06-30, cash was $1.72B against $591.0M of debt.
- Cash
- $1.72B
- Debt
- $591.0M
- Equity
- $6.76B
- Total assets
- $10.96B
- Shares outstanding
- 399,235,889
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $145.0M | -$782.0M | -539.3% | -1.97 |
| Q1 FY 2026 | 2026-03-31 | $389.0M | -$1.34B | -345.2% | -3.40 |
| Q4 FY 2025derived | 2025-12-31 | $678.0M | -$826.0M | -121.8% | n/a |
| Q3 FY 2025 | 2025-09-30 | $1.02B | -$200.0M | -19.7% | -0.51 |
| Q2 FY 2025 | 2025-06-30 | $142.0M | -$825.0M | -581.0% | -2.13 |
| Q1 FY 2025 | 2025-03-31 | $108.0M | -$971.0M | -899.1% | -2.52 |
| Q4 FY 2024derived | 2024-12-31 | $966.0M | -$1.12B | -115.9% | n/a |
| Q3 FY 2024 | 2024-09-30 | $1.86B | $13.0M | 0.7% | 0.03 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1.94B | -$2.82B | -$1.87B | $192.0M | $2.0M | n/a |
| FY 2024 | 2024-12-31 | $3.24B | -$3.56B | -$3.00B | $1.05B | $0 | n/a |
| FY 2023 | 2023-12-31 | $6.85B | -$4.71B | -$3.12B | $707.0M | $1.15B | n/a |
| FY 2022 | 2022-12-31 | $19.26B | $8.36B | $4.98B | $400.0M | $3.33B | n/a |
| FY 2021 | 2021-12-31 | $18.47B | $12.20B | $13.62B | $284.0M | $857.0M | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
Moderna in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Moderna (MRNA), SEC CIK 1682852, listed on Nasdaq, classified by the SEC as biological products, (no diagnostic substances). The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-12.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-31.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 1682852Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as biological products, (no diagnostic substances)
Other company pages
Datasets
Frequently Asked Questions
How much of MRNA is sold short?
32,603,398 shares were held short at the 2026-10-15 settlement, 1.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is MRNA's daily short volume?
On 2026-11-02, 2,296,522 of the 4,074,294 MRNA shares reported to FINRA were sold short, 56.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does MRNA have fails to deliver?
The SEC's latest file shows 453 MRNA shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are MRNA insiders buying or selling?
Insiders at MRNA reported 12 open-market sells worth $62.6M in the last 90 days and no open-market buys. Latest filing: Hoge Stephen (President) on 2026-10-15.
Have MRNA insiders filed to sell?
19 Form 144 notices on file for MRNA worth $85.6M at the prices reported; 7 in the last 90 days worth $62.8M. Latest: Hoge Stephen filed on 2026-10-15 to sell 39,145 shares ($8.6M) from 2026-10-15.
Who owns 5% or more of MRNA?
4 holders report 5% or more of MRNA in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 13.1% of the class (51,803,891 shares), filed 2026-08-06 for an event on 2026-06-30.
What did MRNA report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Moderna reported revenue of $145.0M, up 2.1% from the same quarter a year earlier, and net loss of $782.0M (-1.97 diluted EPS). In FY 2025 it generated -$1.87B of operating cash flow and spent $2.0M on buybacks. As of 2026-06-30, cash was $1.72B against $591.0M of debt.
Which tracked 13F managers own MRNA?
7 of the 30 tracked 13F managers held MRNA shares at their latest filing, $592.0M in all. The largest: Two Sigma Investments (7.2M shares, $503.8M), Cliff Asness's AQR Capital Management (479K shares, $33.6M), Izzy Englander's Millennium Management (439K shares, $30.7M), Ken Griffin's Citadel Advisors (294K shares, $20.6M), D. E. Shaw & Co. (25K shares, $1.7M), Ray Dalio's Bridgewater Associates (12K shares, $807K). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.